Asia-Pacific Cancer Diagnostic Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Asia-Pacific Cancer Diagnostic Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024


  • Products Id :- DBMR39
  • |
  • Pages: 350
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

In this region, Asia-Pacific Cancer Diagnostics Market is accounted to reach USD 7.10 billion by 2024 from USD 2.70 billion in 2016,it is growing at a CAGR of 12.7% in the forecast period 2017 to 2024

The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries.

The key market players for Asia-Pacific Cancer Diagnostics Market are listed below:

Hoffman-La Roche Ltd

Abbott Laboratories Inc

QIAGEN.

The market is further segmented into:

Type

Application

Technology

End User

Geography

The Asia-Pacific cancer diagnostics market is segmented on the basis of technology, application and geography. The Asia-Pacific cancer diagnostics market is segmented into 2 types- platform based and instrument based.

In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

Based on application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Based on geography, the Asia-Pacific Cancer Diagnostics Market is segmented into 11 geographical regions, such as,

China,

Japan,

India,

South Korea,

Australia,

Thailand,

Malaysia,

Singapore,

Indonesia,

Philippines

Rest of Asia-Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia-Pacific Cancer Diagnostics Market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table Of Contents

1. Introduction

1.1. Objectives Of The Study

1.2. Market Definition

1.3. Overview Of Asia-Pacific Cancer Diagnostics Market

1.4. Currency And Pricing

1.5. Limitation

1.6. Markets Covered

2. Market Segmentation

2.1. Markets Covered

2.2. Geographic Scope

2.3. Years Considered For The Study

2.4. Currency And Pricing

2.5. Research Methodology

2.6. Primary Interviews With Key Opinion Leaders

2.7. Secondary Sources

2.8. Assumptions

3. Market Overview

3.1. Drivers

3.1.1. Growth Of Aging Population And Rising Prevalence Of Cancer

3.1.2. Government Initiatives For Funding And Awareness About Cancer

3.1.3. Key Players Focusing On Strategic Decisions To Gain Market Share

3.1.4. Increasing Prevelance Of Cancer

3.2. Restraints

3.2.1. Stringent Reulations Imposed By International And Local Authorities

3.2.2. Shortage Of Skilled And Trained Professionals

3.3. Opportunities

3.3.1. Nanotechnology: Forthcoming Revolution In Cancer Diagnosis

3.3.2. Artificial Intelligence And The Imminent

Health Revolution

3.3.3. Growing Medical Tourism In Asia

3.4. Challenges

3.4.1. Increasing Rivalry Among The Competitors

3.4.2. Poor Access To Cancer Detection And High Treatment Cocts In Lower Income Countries

4. Premium Insights

5. Executive Summary

6. Asia-Pacific Cancer Diagnostics Market, By Technology

6.1. Overview

6.2. Platform Based

6.2.1. Polymerase Chain Reaction(Pcr)

6.2.2. In Situ Hybridization (Ish)

6.2.3. Immunohistochemistry(Ihc)

6.2.4. Next Generation Sequencing (Ngs)

6.2.5. Dna Microarrays

6.2.6. Flow Cytometry

6.3. Instrument Based

6.3.1. Imaging

6.3.1.1. Magentic Resonance Imaging (Mri)

6.3.1.2. Ct(Computed Tomography)

6.3.1.3. Positron Emission Tomography- Computed Tomography (Pet-Ct)

6.3.1.4. Mammography

6.3.1.5. Ultrasound

6.3.2. Biopsy

7. Asia-Pacific Cancer Diagnostics Market, By Application

7.1. Overview

7.2. Lung Cancer

7.3. Breast Cancer

7.4. Colorectal Cancer

7.5. Melanoma

7.6. Others

8. Asia-Pacific Cancer Diagnostics Market, By Geography

8.1. Overview

8.2. Asia-Pacific Cancer Diagnostics Market

8.2.1. Japan Cancer Diagnostics Market

8.2.2. China Cancer Diagnostics Market

8.2.3. India Cancer Diagnostics Market

8.2.4. South Korea Cancer Diagnostics Market

8.2.5. Australia Cancer Diagnostics Market

8.2.6. Thailand Cancer Diagnostics Market

8.2.7. Singapore Cancer Diagnostics Market

8.2.8. Malaysia Cancer Diagnostics Market

8.2.9. Indonesia Cancer Diagnostics Market

8.2.10. Philippines Cancer Diagnostics Market

8.2.11. Rest Of Asia-Pacific Cancer Diagnostics Market

9. Asia-Pacific Cancer Diagnostics Market, Company Landscape

9.1. Company Share Analysis: Asia-Pacific Cancer Diagnostics Imaging Market

9.2. Company Share Analysis: Asia-Pacific Cancer Diagnostics Platform Based Market

10. Company Profiles

10.1. C. R. Bard, Inc.

10.1.1. Company Overview

10.1.2. Revenue Analysis

10.1.3. Product Portfolio

10.1.4. Recent Developments

10.2. Illumina, Inc.

10.2.1. Company Overview

10.2.2. Revenue Analysis

10.2.3. Recent Developments

10.2.4. Product Portfolio

10.3. Qiagen

10.3.1. Company Overview

10.3.2. Revenue Analysis

10.3.3. Recent Developments

10.3.4. Product Portfolio

10.4. Abbott

10.4.1. Company Overview

10.4.2. Revenue Analysis

10.4.3. Recent Developments

10.4.4. Product Portfolio

10.5. Siemens Healthcare Gmbh

10.5.1. Company Overview

10.5.2. Revenue Analysis

10.5.3. Recent Developments

10.5.4. Product Portfolio

10.6. Agilent Technologies

10.6.1. Company Overview

10.6.2. Revenue Analysis

10.6.3. Product Portfolio

10.6.4. Recent Developments

10.7. Thermo Fisher Scientific Inc.

10.7.1. Company Overview

10.7.2. Revenue Analysis

10.7.3. Product Portfolio

10.7.4. Recent Developments

10.8. Becton, Dickinson And Company

10.8.1. Company Overview

10.8.2. Revenue Analysis

10.8.3. Product Portfolio

10.8.4. Recent Developments

10.9. Ge Healthcare

10.9.1. Company Overview

10.9.2. Revenue Analysis

10.9.3. Product Portfolio

10.9.4. Recent Developments

10.10. F. Hoffmann-La Roche Ltd

10.10.1. Company Overview

10.10.2. Revenue Analysis

10.10.3. Product Portfolio

10.10.4. Recent Developments

10.11. Hologic Inc.

10.11.1. Company Overview

10.11.2. Revenue Analysis

10.11.3. Recent Developments

10.11.4. Product Portfolio

10.12. Koninklijhe Philips N.V.

10.12.1. Company Overview

10.12.2. Revenue Analysis

10.12.3. Product Portfolio

10.12.4. Recent Developments

11. Related Reports

Figures List

Figure 1 Asia-Pacific And South America Are The Highest Growing And Most Profitable Revenue Pockets For Cancer Diagnostics Manufacturers In The Forecast Period 2017 To 2024

Figure 2 Asia-Pacific Cancer Diagnostics Market : Snapshot (2017)

Figure 3 Asia-Pacific Cancer Diagnostics Market, By Country (2016)

Figure 4 Asia-Pacific Cancer Diagnostics Market : By Country (2017)

Figure 5 Asia-Pacific Cancer Diagnostics Market By Country (2016 & 2024)

Figure 6 Asia-Pacific Cancer Diagnostics Market, By Technology (2017 & 2024)

Table List

Table 1 Asia-Pacific Cancer Diagnostics Market, By Country, 2015-2024 (Usd Million)

Table 2 Asia-Pacific Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 3 Asia-Pacific Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 4 Asia-Pacific Instrument Based Imaging Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 5 Asia-Pacific Instrument Based Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 6 Asia-Pacific Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 7 Japancancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 8 Japan Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 9 Japan Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 10 Japan Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 11 Japan Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 12 China Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 13 China Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 14 China Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 15 China Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 16 China Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 17 Indiacancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 18 India Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 19 India Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 20 India Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 21 India Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 22 South Korea Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 23 South Korea Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 24 South Korea Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 25 South Korea Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 26 South Korea Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 27 Australiacancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 28 Australia Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 29 Australia Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 30 Australia Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 31 Australia Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 32 Thailand Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 33 Thailand Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 34 Thailand Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 35 Thailand Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 36 Thailand Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 37 Singapore Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 38 Singapore Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 39 Singapore Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 40 Singapore Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 41 Singapore Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 42 Malaysia Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 43 Malaysia Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 44 Malaysia Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 45 Malaysia Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 46 Malaysia Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 47 Indonesia Cancer Diagnostics Market, By Technology,

2015-2024 (Usd Million)

Table 48 Indonesia Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 49 Indonesia Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 50 Indonesia Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 51 Indonesia Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 52 Philippines Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 53 Phillipines Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 54 Philippines Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 55 Philippines Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 56 Philippines Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

Table 57 Rest Of Asia-Pacific Cancer Diagnostics Market, By Technology, 2015-2024 (Usd Million)

Table 58 Rest Of Asia-Pacific Platform Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 59 Rest Of Asia-Pacific Instrument Based Cancer Diagnostics Market, By Product Type, 2015-2024 (Usd Million)

Table 60 Rest Of Asia-Pacific Instrument Based Imaging Cancer Diagnostics Market, By Imaging Type, 2015-2024 (Usd Million)

Table 61 Rest Of Asia-Pacific Cancer Diagnostics Market, By Application 2015-2024 (Usd Million)

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Hoffman-La Roche Ltd

Abbott Laboratories Inc

QIAGEN.

select a license
Single User License
USD 4200 INR 302064
Corporate User License
USD 5400 INR 388368

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com